France Fines J&J 25 Million Euros Over Painkiller Patch

Dec 20, 2017

On Wednesday, France's competition authority fined U.S. healthcare group Johnson & Johnson 25 million euros , after it ruled the company had deliberately slowed market access to generic copies of its painkiller Durogesic. Durogesic is sold as a skin patch to control ongoing moderate to severe pain and is often prescribed in cancer cases. It contains fentanyl, an opioid which, if misused, can lead to death by overdose.